期刊文献+

NOD小鼠未成熟树突状细胞体外诱导淋巴细胞生成并扩增调节性T细胞的研究 被引量:2

Research on induction and expansion of regulatory T cells by immature dendritic cells of NOD mice in vitro
下载PDF
导出
摘要 目的探索非肥胖糖尿病(non-obese diabetic,NOD)小鼠未成熟树突状细胞(immature dendritic cell,imDC)诱导并扩增调节性T细胞(regulatory Tcells,Treg)的优化方案。方法分离、培养NOD小鼠骨髓来源的imDC和淋巴细胞,并进行混合淋巴细胞培养,分别加入白介素(IL)-2、转化生长因子(transforming growth factor,TGF)-β1、抗CD3抗体和抗CD28抗体刺激淋巴细胞增殖、分化。实验分为4组:对照组(淋巴细胞+IL-2)、实验1组(淋巴细胞+imDC+TGF-β1+IL-2)、实验2组(淋巴细胞+imDC+抗CD3抗体+抗CD28抗体+IL-2)、实验3组(淋巴细胞+imDC+抗CD3抗体+抗CD28抗体+TGF-β1+IL-2)。用流式细胞仪检测各组培养3d后淋巴细胞的扩增情况及混合培养6d淋巴细胞中CD4、CD25及Foxp3的表达。结果 imDC和淋巴细胞混合培养3d后,对照组、实验1组、实验2组和实验3组增殖指数分别为(1.04±0.03)%、(1.26±0.02)%、(1.36±0.01)%和(1.55±0.02)%。实验3组的增殖指数较实验1组和实验2组明显升高(均为P<0.01)。混合培养6d后,对照组、实验1组、实验2组和实验3组的CD4+CD25+T淋巴细胞亚群所占比例分别为(2.41±0.02)%、(17.98±1.02)%、(30.67±2.68)%、(42.84±1.41)%,而CD4+CD25+T淋巴细胞中Foxp3+细胞的比例4组分别为(65.55±1.41)%、(86±1.72)%、(70.29±1.39)%、(92.3±1.99)%,实验3组的淋巴细胞CD4+CD25+、Foxp3+的表达水平较实验1组和实验2组明显升高(均为P<0.01)。结论在imDC和淋巴细胞混合培养时加入TGF-β1、抗CD3抗体、抗CD28抗体可明显刺激imDC诱导扩增Treg,是体外诱导扩增Treg的理想方案之一。 Objective To explore a novel protocol of efficient induction and expansion of CD4+CD25+Foxp3+regulatory T cells with immature dendritic cells(imDC)from non-obese diabetic(NOD)mouse in vitro.Methods The imDC and lymph cells from NOD mouse were isolated,mixed and then co-cultured.Interleukin-2(IL-2),transforming growth factor(TGF)-β1,CD3 antibody(anti-CD3)as well as CD28 antibody(anti-CD28)were added to the mixed lymphocyte reaction(MLR)to induce regulatory T cells respectively.The experiment were divided into 4 groups:control group(lymph cells+IL-2),experimental group 1(lymph cells+imDC+TGF-β1+IL-2),experimental group 2(lymph cells+imDC+anti-CD3+anti-CD28+IL-2)and experimental group 3(lymph cells+imDC+anti-CD3+anti-CD28+TGF-β1+IL-2).MLR were cultured for 3 days and the lymphocyte expansion was detected by flow cytometry.The expressions of CD4,CD25 and Foxp3 on lymphocytes were also detected by flow cytomer on day 6 after co-culture.Results Proliferation index(PI)of control group,experimental group 1,experimental group 2 and experimental group 3 were(1.04±0.03)%,(1.26±0.02)%,(1.36±0.01)% and(1.55±0.02)% respectively.The PI of experimental group 3 was significantly higher than those of experimental group 2 and experimental group 1(all in P0.01).The proportion of CD4+CD25+T cells in control group,experimental group 1,experimental group 2,experimental group 3 were(2.41±0.02)%,(17.98±1.02)%,(30.67±2.68)%,and(42.84±1.41)% respectively.The proportion of Foxp3+cells in CD4+CD25+T cells of control group,experimental group 1,experimental group 2,experimental group 3 were(65.55±1.41)%,(86.00±1.72)%,(70.29±1.39)% and(92.30±1.99)% respectively.The expressions of CD4+CD25+and Foxp3+in experimental group 3 were significantly higher compared with experimental group 2 and experimental group 1(all in P0.01).Conclusion In the co-culture of imDC and lymphocytes,TGF-β1,anti-CD3 and anti-CD28 can significantly induce imDC and subsequently lead to regulatory T cells expansion,which is an efficient method to induce and expand regulatory T cells.
出处 《器官移植》 CAS 2011年第3期129-134,共6页 Organ Transplantation
基金 国家自然科学基金面上项目(30872388)
关键词 未成熟树突状细胞 非肥胖糖尿病 小鼠 转化生长因子-β1 抗CD3抗体 抗CD28抗体 调节性T细胞 Immature dendritic cell Non-obese diabetic Mouse Transforming growth factor-β1 CD3 antibody CD28 antibody Regulatory T cells
  • 相关文献

参考文献15

  • 1Sakaguchi S,Sakaguchi N.Regulatory T cells in immunologic self-tolerance and autoimmune disease[J].Int Rev Immunol,2005,24(3-4):211-226.
  • 2Giarratana N,Penna G,Adorini L.Animal models of spontaneous autoimmune disease:type 1 diabetes in the nonobese diabetic mouse[J].Methods Mol Biol,2007,380:285-311.
  • 3Rabinovitch A,Suarez-Pinzon WL.Roles of cytokines in the pathogenesis and therapy of type 1 diabetes[J].Cell Biochem Biophys,2007,48(2-3):159-163.
  • 4Khattri R,Cox T,Yasayko SA,et al.An essential role for Scurfin in CD4+CD25+T regulatory cells[J].Nat Immunol,2003,4(4):337-342.
  • 5Fu S,Zhang N,Yopp AC,et al.TGF-beta induces Foxp3+T-regulatory cells from CD4+CD25-precursors[J].Am J Transplant,2004,4(10):1614-1627.
  • 6Nadig SN,Wieckiewicz J,Wu DC,et al.In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells[J].Nat Med,2010,16(7):809-813.
  • 7黄立锋,姚咏明,盛志勇.树突状细胞与调节性T细胞相互作用研究进展[J].中国病理生理杂志,2008,24(3):610-616. 被引量:16
  • 8Pothoven KL,Kheradmand T,Yang Q,et al.Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation[J].Am J Transplant,2010,10(8):1774-1784.
  • 9Marguti I,Yamamoto GL,da Costa TB,et al.Expansion of CD4+CD25+Foxp3+T cells by bone marrow-derived dendritic cells[J].Immunology,2009,127(1):50-61.
  • 10Takahashi T,Kuniyasu Y,Toda M,et al.Immunologic self-tolerance maintained by CD25+CD4+naturally anergic and suppressive T cells:induction of autoimmune disease by breaking their anergic/suppressive state[J].Int Immunol,1998,10(12):1969-1980.

二级参考文献32

  • 1林东军,方志刚,付咏梅,李旭东,黄仁魏.肿瘤抗原联合CD40L致敏树突状细胞诱导CTLs杀伤K562细胞的实验研究[J].中国病理生理杂志,2006,22(9):1751-1755. 被引量:2
  • 2湛海伦,高新,邱剑光,蔡育彬,司徒杰,温星桥.抗原致敏DC与CIK共培养体外抗肾癌效应的研究[J].中国病理生理杂志,2006,22(10):1993-1996. 被引量:9
  • 3Chatila TA. Role of regulatory T cells in human diseases [J]. Allergy Clin Immunol, 2005, 116(5) :949 -959.
  • 4Hock BD, Roberts G, McKenzie JL, et al. Exposure to the electrofusion process can increase the immunogenicity of human cells [J]. Cancer Immunol Immunother, 2005, 54(9) :880 - 890.
  • 5Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25 + CD4 + regulatory T cells [ J ]. Int Immunol, 2005, 16 ( 11 ) :1643 - 1656.
  • 6Fehervari Z, Sakaguchi S. Development and function of CD25^+ CD^4+ regulatory T cells [ J ]. Curr Opin Immunol, 2004, 16(2) :203 - 208.
  • 7Oderup C, Cederbom L, Makowska A, et al. Cytotoxic T lymphocyte antigen -4 - dependent down - modulation of costimulatory molecules on dendritic cells in CD4 + CD25^+ regulatory T - cell - mediated suppression [ J ]. Immunology, 2006, 118(2) : 240 -249.
  • 8Wang Z, Larregina AT, Shufesky W J, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T - cell deletion and regulatory T cells [J]. Am J Transplant, 2006, 6(6) :1297 -1311.
  • 9Houot R, Perrot I, Garcia E, et al. Human CD4+ CD25 high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation[ J]. J Immunol, 2006, 176 (9) : 5293 - 5298.
  • 10van Meirvenne S, Dullaers M, Heirman C, et al. In vivo depletion of CD4 + CD25 + regulatory T cells enhances the antigen - specific primary and memory CTL response elicited by mature mRNA -electroporated dendritic cells [ J]. Mol Ther, 2005, 12(5) :922 - 932.

共引文献15

同被引文献57

  • 1hoh M, Takahashi T, Sakaguchi N, et al. Thymus and au- toimmunity: production of CD25 ^+ CD4 ^+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance [J]. J Immunol, 1999, 162 (9): 5317-5326.
  • 2Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) . breakdown of a sin- gle mechanism of self-tolerance causes various autoimmune diseases [J]. J Immunol, 1995, 155 (3): 1151-1164.
  • 3Jiang S, Lechler RI, He XS, et al. Regulatory T cells and transplantation tolerance [ J ]. Hum Immunol, 2006, 67 (10) : 765-776.
  • 4Kang SM, Tang Q, Bluestone JA. CD4 ^+ CD25 ^+ regulatory T cells in transplantation: progress, challenges and pros- pects [J]. Am J Transplant, 2007, 7 (6) : 1457-1463.
  • 5Dainiak MB, Kumar A, Galaev IY, et al. Methods in cell separations [ J ]. Adv Biochem Eng Biotechnol, 2007, 106: 1-18.
  • 6Di Ianni M, Del Papa B, Cecchini D, et al. Immunomag- netic isolation of CIM ^+ CD25 ^+ FoxP3 ^+ natural T regulatory lymphocytes for clinical applications [J].Clin Exp Immu- nol, 2009, 156 (2): 246-253.
  • 7Bresatz S, Sadlon T, Millard D, et al. Isolation, propaga- tion and characterization of cord blood derived CD4^+ CD25^+ regulatory T ceils [J]. J Immunol Methods, 2007, 327 (1-2) : 53- 62.
  • 8Hoffmann P, Boeld TJ, Eder R, et al. Isolation of CD4^+ CD25^+ regulatory T cells for clinical trims [J]. Biol Blood Marrow Transplant, 2006, 12 (3): 267-274.
  • 9Dieckmann D, Plottner H, Berchtold S, et al. Ex vivo iso- lation and characterization of CIM ( + ) CD25 ( + ) Tcells with regulatory properties from human blood [ J]. J ExpMed, 2001, 193 (11): 1303-1310.
  • 10Paust S, Lu L, MeCarty N, et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease [J]. Proc Natl Acad Sci U S A, 2004, 101 (28) : 10398-10403.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部